News & Updates

Show Multimedia Only
Airflow limitation predicts muscle wasting in COPD patients

Airflow limitation predicts muscle wasting in COPD patients

09 Sep 2023
Primary PCI strategy reduces death rates in STEMI patients

Primary PCI strategy reduces death rates in STEMI patients

09 Sep 2023

Between 2003 and 2018, 1-year mortality has decreased considerably in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) in a high-income European country with a fully implemented primary PCI strategy, reports a study.

Primary PCI strategy reduces death rates in STEMI patients

09 Sep 2023
Inadequate sleep tied to higher incidence of urgent urinary incontinence

Inadequate sleep tied to higher incidence of urgent urinary incontinence

09 Sep 2023

Urgent urinary incontinence appears to occur more frequently among people with insufficient sleep than among those with moderate sleep duration, according to a study.

Inadequate sleep tied to higher incidence of urgent urinary incontinence

09 Sep 2023
Dapagliflozin safe, effective in HF patients across global regions

Dapagliflozin safe, effective in HF patients across global regions

08 Sep 2023 byStephen Padilla

Dapagliflozin for individuals with heart failure (HF) demonstrates consistent safety and efficacy across regions worldwide despite geographic differences in patient characteristics, background treatment, and event rates, reports a recent study.

Dapagliflozin safe, effective in HF patients across global regions

08 Sep 2023
Depression ups risk of CVD, mortality

Depression ups risk of CVD, mortality

08 Sep 2023 byStephen Padilla

Individuals with depression are at higher risk of developing cardiovascular disease (CVD), which may even result in death, suggests a recent study.

Depression ups risk of CVD, mortality

08 Sep 2023
Hydrocortisone cuts mortality risk in ICU patients with severe pneumonia

Hydrocortisone cuts mortality risk in ICU patients with severe pneumonia

08 Sep 2023 byAudrey Abella

In patients admitted to the intensive care unit (ICU) for severe community-acquired pneumonia (CAP), those who received hydrocortisone had a lower mortality risk compared with those on placebo, findings from the CAPE COD* trial suggest.

Hydrocortisone cuts mortality risk in ICU patients with severe pneumonia

08 Sep 2023